| ¡Our
Organization! |
Founded in 1979, IQB is a Spanish independant organization
devoted to the design and development of New Chemical Entities as new Drugs
and to the diffusion of Scientific Information using the lastest multimedia
tools |
| Drugs
and Licences |
Drugs
discovered at IQB are licenced to Pharmaceutical Companies for their further
preclinical and clinical development and, finally, for their commercial
explotation.
Drugs
- Guanylcysteine (mucolytic):licenced
to Laboratorios Berenguer-Beneyto (Madrid, Spain)
- Oxodipine (calcium channel blocker): licenced
to Laboratoires DELAGRANGE (Paris, France)
- Elgodipine (calcium channel blocker): licenced
to Laboratoires DELAGRANGE and Synthélabo (Paris, France) and
to PRODESFARMA-ALMIRALL (Barcelona, Spain)
- Ipravacaine(local anesthetic): INIBSA (Barcelona,
Spain)
|
| Projects
|
IQB has been involved in the EUREKA 59 y EUREKA
625 projects in collaboration with DELAGRANGE |
| Other Research
Projects |
- Tyrosine Kinase Inhibitors: Design program of new molecules
with tyrosine kinase inhibitory activity useful as PDGF antagonists
- Chrono-histamines: new generation of antihistamines with improved
brain penetration and short metabolic half-life useful as non-benzodiazepine
non-barbituric sleep inducers.
|
| Address |
Tebas, 20
28230 Las Rozas (Madrid)
Spain
|
| |
FACILITIES
|
